Work

Abstract A031: DNA-PK reenforces the S/G2 checkpoint in ATM-deficient cells to limit ATR inhibitor efficacy

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-a031

Authors: Timothy B. Branigan, Roshen Alharthi, Bose S. Kochpurakkal, Jie Hao, Steffie Revia, Mu-Yan Cai, Yuqing Jiao, David B. Martignetti, Sirisha Mukkavalli, Ian A. Roundtree, Gregory M. Cote, Prafulla C. Gokhale, Kalindi Parmar, Alan D. D'Andrea, Astrid Zimmermann, Geoffrey I. Shapiro

Institutions: Dana-Farber Cancer Institute, Merck Healthcare KGaA, Darmstadt (Germany), Massachusetts General Hospital

Language: English

Topic: DNA Repair Mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444781

Cites:

Cited by:

Related to: